A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs

Clinical trial NCT04428346 · UNKNOWN

Trial details

NCT number: NCT04428346
Sponsor: Kirby Institute
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2022-10-01
Primary completion: 2023-09-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.